Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
embryonic stem cell-derived mesenchymal stem cells
- Development stage
- Preclinical
- Lead developer
- Daewoong Pharmaceutical
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intra-arterial
01
Overview
Embryonic stem cell-derived mesenchymal stem cells (ES-MSCs) are a specialized population of mesenchymal stem cells generated from human embryonic stem cell (hESC) lines. They are being investigated as a therapeutic platform for neurodegenerative diseases, most notably Alzheimer's disease (AD). Preclinical studies indicate that ES-MSCs can reduce the accumulation of amyloid-beta (Aβ) in the brain by enhancing autophagolysosomal clearance mechanisms. Additionally, these cells demonstrate superior viability and neuroprotective capacity compared to traditional bone marrow-derived MSCs (BM-MSCs) in amyloid-rich environments. Clinical interest in ES-MSCs stems from their potential for large-scale production and their ability to improve cognitive function and inhibit hippocampal cell death when administered via intra-arterial or other systemic routes.
- Other names
- hES-MSCshuman embryonic stem cell-derived mesenchymal stem cellsESC-MSCs
Beyond the preview
Go deeper on embryonic stem cell-derived mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on embryonic stem cell-derived mesenchymal stem cells.